News - BioPharm International

ADVERTISEMENT

News

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B

October 30, 2014

Pfizer's Trumenba is the first FDA-approved immunization against meningococcal disease for individuals 10-25 years old.

Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment

October 29, 2014

Bristol-Myers Squibb announced that they have reached an agreement with F-star Alpha, giving BMS the exclusive option to acquire F-star's HER2-targeted breast and gastric cancer treatment.

Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research

October 28, 2014

New research will focus on a superfamily of protein receptors linked to various diseases.

Yale and Gilead Extend Sequencing Initiative

October 28, 2014

The Yale School of Medicine and Gilead will continue their research on cancer targets for a minimum of three additional years.

Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million

October 28, 2014

The company receives backing to continue its work in research services, process development, and cGMP manufacturing activities.

Novartis Sells Influenza Vaccine Business to CSL for $275 Million

October 27, 2014

The divestment will create the number two player in the global influenza vaccine industry.

Baxter Recalls Two Lots of IntraVia

October 27, 2014

Two lots of empty intravenous fluid bags were voluntarily recalled because of the presence of particulates.

Despite AbbVie Snub, Shire Says it Will Double Sales by 2020

October 24, 2014

Shire announces it will expand its orphan drug portfolio and is ready for future M&A discussions.

J&J Speeds Ebola Vaccine Development and Expands Production

October 24, 2014

Johnson& Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an ebola vaccine.

ADVERTISEMENT

ADVERTISEMENT

Click here